The differential effect of morphine and β-endorphin administered intracerebroventricularly on pERK and pCaMK-II expression induced by various nociceptive stimuli in mice brains

Neuropeptides

Volumn 42, Issue 3, 2008, Pages 319-330

  Seo, Young Jun ^a   Kwon, Min Soo ^a   Choi, Hee Woo ^a   Jang, Jeong Eun ^a   Lee, Jin Koo ^a   Jung, Jun Sub ^a   Park, Soo Hyun ^a   Suh, Hong Won ^a  

^a Hallym University   (South Korea)

Author keywords

Endorphin; Formalin; Morphine; Phosphor CaMK II; Phosphor ERK; Substance P

Indexed keywords

BETA ENDORPHIN; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE 2 ALPHA; MITOGEN ACTIVATED PROTEIN KINASE; MORPHINE; PROTEIN KINASE (CALCIUM,CALMODULIN) II;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; ATTENUATION; BRAIN; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME PHOSPHORYLATION; HYPOTHALAMUS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INJECTION; LOCUS CERULEUS; MALE; MOLECULE; MOUSE; NOCICEPTIVE STIMULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE; THALAMUS MIDLINE NUCLEUS;

ANALGESICS, OPIOID; ANIMALS; BETA-ENDORPHIN; BLOTTING, WESTERN; BRAIN CHEMISTRY; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FORMALDEHYDE; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAVENTRICULAR; INJECTIONS, SPINAL; MALE; MICE; MICE, INBRED ICR; MORPHINE; PAIN; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; SUBSTANCE P;

MUS;

EID: 44649102685     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.npep.2008.01.003     Document Type: Article

References (53)

1. Bloom F., et al. Neurons containing beta-endorphin in rat brain exist separately from those containing enkephalin: immunocytochemical studies. Proc. Natl. Acad. Sci. USA 75 (1978) 1591-1595
2. Bronstein D.M., et al. Evidence that beta-endorphin is synthesized in cells in the nucleus tractus solitarius: detection of POMC mRNA. Brain Res. 587 (1992) 269-275
3. Charmandari E., et al. Endocrinology of the stress response. Annu. Rev. Physiol. 67 (2005) 259-284
4. Choi S.S., et al. Increase of phosphorylation of calcium/calmodulin-dependent protein kinase-II in several brain regions by substance P administered intrathecally in mice. Brain Res. Bull. 65 (2005) 375-381
5. Choi S.S., et al. Involvement of phosphorylated extracellular signal-regulated kinase in the mouse substance P pain model. Brain Res. Mol. Brain Res. 137 (2005) 152-158
6. 2+/calmodulin-dependent protein kinase II and phosphorylated extracellular signal-regulated protein in the mouse formalin pain model. Brain Res. 1108 (2006) 28-38
7. Contet C., et al. No evidence for G-protein-coupled epsilon receptor in the brain of triple opioid receptor knockout mouse. Eur. J. Pharmacol. 492 (2004) 131-136
8. Dai Y., et al. Phosphorylation of extracellular signal-regulated kinase in primary afferent neurons by noxious stimuli and its involvement in peripheral sensitization. J. Neurosci. 22 (2002) 7737-7745
9. Fan G.H., et al. Inhibition of calcium/calmodulin-dependent protein kinase II in rat hippocampus attenuates morphine tolerance and dependence. Mol. Pharmacol. 56 (1999) 39-45
10. Galan A., et al. Activation of spinal extracellular signaling-regulated kinase-1 and -2 by intraplantar carrageenan in rodents. Neurosci. Lett. 322 (2002) 37-40
11. Gioia M., et al. Extracellular signal-regulated kinases 1 and 2 phosphorylated neurons in the tele- and diencephalon of rat after visceral pain stimulation: an immunocytochemical study. Neurosci. Lett. 308 (2001) 177-180
12. Hunskaar S., and Hole K. The formalin test in mice: dissociation between inflammatory and non-inflammatory pain. Pain 30 (1987) 103-114
13. Hylden J.L., and Wilcox G.L. Intrathecal morphine in mice: a new technique. Eur. J. Pharmacol. 67 (1980) 313-316
14. Hylden J.L., and Wilcox G.L. Intrathecal substance P elicits a caudally-directed biting and scratching behavior in mice. Brain Res. 217 (1981) 212-215
15. Hylden J.L., and Wilcox G.L. Intrathecal substance P elicits a caudally-directed biting and scratching behavior in mice. Brain Res. 217 (1981) 212-215
16. Ji R.R., and Woolf C.J. Neuronal plasticity and signal transduction in nociceptive neurons: implications for the initiation and maintenance of pathological pain. Neurobiol. Dis. 8 (2001) 1-10
17. Ji R.R., et al. Nociceptive-specific activation of ERK in spinal neurons contributes to pain hypersensitivity. Nat. Neurosci. 2 (1999) 1114-1119
18. Ji R.R., et al. ERK MAP kinase activation in superficial spinal cord neurons induces prodynorphin and NK-1 upregulation and contributes to persistent inflammatory pain hypersensitivity. J. Neurosci. 22 (2002) 478-485
19. Ji R.R., et al. Protein kinases as potential targets for the treatment of pathological pain. Handb. Exp. Pharmacol. (2007) 359-389
20. Karim F., et al. Metabotropic glutamate receptor subtypes 1 and 5 are activators of extracellular signal-regulated kinase signaling required for inflammatory pain in mice. J. Neurosci. 21 (2001) 3771-3779
21. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
22. Lariviere W.R., and Melzack R. The role of corticotropin-releasing factor in pain and analgesia. Pain 84 (2000) 1-12
23. Laursen S.E., and Belknap J.K. Intracerebroventricular injections in mice. Some methodological refinements. J. Pharmacol. Methods 16 (1986) 355-357
24. Lechner S.M., and Valentino R.J. Glucocorticoid receptor-immunoreactivity in corticotrophin-releasing factor afferents to the locus coeruleus. Brain Res. 816 (1999) 17-28
25. Lu L., et al. Inhibition of the amygdala and hippocampal calcium/calmodulin-dependent protein kinase II attenuates the dependence and relapse to morphine differently in rats. Neurosci. Lett. 291 (2000) 191-195
26. Ma Q.P., and Woolf C.J. Progressive tactile hypersensitivity: an inflammation-induced incremental increase in the excitability of the spinal cord. Pain 67 (1996) 97-106
27. Millan M.J. The induction of pain: an integrative review. Prog. Neurobiol. 57 (1999) 1-164
28. Mizoguchi H., et al. Differential involvement of mu(1)-opioid receptors in endomorphin- and beta-endorphin-induced G-protein activation in the mouse pons/medulla. Neuroscience 100 (2000) 835-839
29. Morris J.F., et al. Dendritic secretion of peptides from hypothalamic magnocellular neurosecretory neurones: a local dynamic control system and its functions. Exp. Physiol. 85 Spec No (2000) 131S-138S
30. Muller D.L., and Unterwald E.M. In vivo regulation of extracellular signal-regulated protein kinase (ERK) and protein kinase B (Akt) phosphorylation by acute and chronic morphine. J. Pharmacol. Exp. Ther. 310 (2004) 774-782
31. Narita M., et al. Effect of repeated administration of morphine on the activity of extracellular signal regulated kinase in the mouse brain. Neurosci. Lett. 324 (2002) 97-100
32. Narita M., et al. Role of the calcium/calmodulin-dependent protein kinase ii (CaMKII) in the morphine-induced pharmacological effects in the mouse. Neuroscience 126 (2004) 415-421
33. Ortiz J., et al. Extracellular signal-regulated protein kinases (ERKs) and ERK kinase (MEK) in brain: regional distribution and regulation by chronic morphine. J. Neurosci. 15 (1995) 1285-1297
34. Raynor K., et al. Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors. Mol. Pharmacol. 45 (1994) 330-334
35. Reyes B.A., et al. Hypothalamic projections to locus coeruleus neurons in rat brain. Eur. J. Neurosci. 22 (2005) 93-106
36. Rutz J.C., et al. Localized increases in corticotropin-releasing factor receptors in pulp after dental injury. J. Endodont. 33 (2007) 1319-1324
37. Sawchenko P.E., and Swanson L.W. The organization of forebrain afferents to the paraventricular and supraoptic nuclei of the rat. J. Comp. Neurol. 218 (1983) 121-144
38. Schulz R., et al. Opioid control of MAP kinase cascade. Eur. J. Pharmacol. 500 (2004) 487-497
39. Suh H.H., and Tseng L.F. Delta but not mu-opioid receptors in the spinal cord are involved in antinociception induced by beta-endorphin given intracerebroventricularly in mice. J. Pharmacol. Exp. Ther. 253 (1990) 981-986
40. Suh H.H., and Tseng L.F. Lack of antinociceptive cross-tolerance between intracerebroventricularly administered beta-endorphin and morphine or DPDPE in mice. Life Sci. 46 (1990) 759-765
41. Sun Y.G., et al. Involvement of endogenous beta-endorphin in antinociception in the arcuate nucleus of hypothalamus in rats with inflammation. Pain 104 (2003) 55-63
42. Tien D., et al. Vagal afferents are necessary for the establishment but not the maintenance of kainic acid-induced hyperalgesia in mice. Pain 102 (2003) 39-49
43. Towbin H., et al. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 76 (1979) 257-261
44. Tseng L.F. Evidence for epsilon-opioid receptor-mediated beta-endorphin-induced analgesia. Trends Pharmacol. Sci. 22 (2001) 623-630
45. Tseng L.F., and Wang Q. Forebrain sites differentially sensitive to beta-endorphin and morphine for analgesia and release of Met-enkephalin in the pentobarbital-anesthesized rat. J. Pharmacol. Exp. Ther. 261 (1992) 1028-1036
46. Tseng L.L., and Suh H.H. Intrathecal [Met5]enkephalin antibody blocks analgesia induced by intracerebroventricular beta-endorphin but not morphine in mice. Eur. J. Pharmacol. 173 (1989) 171-176
47. Tseng L.F., et al. Release of immunoreactive met-enkephalin from the spinal cord by intraventricular beta-endorphin but not morphine in anesthetized rats. Brain Res. 343 (1985) 60-69
48. Tseng L.F., et al. Release of immunoreactive Met-enkephalin by intraventricular beta-endorphin in anesthetized rats. Regul. Pept. 14 (1986) 181-192
49. Valentino R.J., and Foote S.L. Corticotropin-releasing hormone increases tonic but not sensory-evoked activity of noradrenergic locus coeruleus neurons in unanesthetized rats. J. Neurosci. 8 (1988) 1016-1025
50. Willis W.D. Role of neurotransmitters in sensitization of pain responses. Ann. NY Acad. Sci. 933 (2001) 142-156
51. Yamamori E., et al. Calcium/calmodulin kinase IV pathway is involved in the transcriptional regulation of the corticotropin-releasing hormone gene promoter in neuronal cells. J. Mol. Endocrinol. 33 (2004) 639-649
52. Yang J., et al. Loss of signaling through the G protein, Gz, results in abnormal platelet activation and altered responses to psychoactive drugs. Proc. Natl. Acad. Sci. USA 97 (2000) 9984-9989
53. Yang S.H., et al. Transcriptional regulation by the MAP kinase signaling cascades. Gene 320 (2003) 3-21